'Diet and lifestyle' in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members [0.03%]
“饮食和生活方式”在血脂异常管理及心血管疾病预防中的作用——欧洲动脉粥样硬化学会成员对知识和兴趣的理解
Elke A Trautwein,Alberico L Catapano,Lale Tokgözoğlu
Elke A Trautwein
To better understand the level of knowledge and interest in 'diet and lifestyle' for cholesterol management and CVD prevention, European Atherosclerosis Society (EAS) members were invited to take part in an online survey. In total, 269 EAS ...
Improving lipid management in patients with acute coronary syndrome: The ACS Lipid EuroPath tool [0.03%]
急性冠脉综合征患者血脂管理的改善：ACS血脂EuroPath工具
Alessandro Sionis,Alberico L Catapano,Gaetano M De Ferrari et al.
Alessandro Sionis et al.
Post-acute coronary syndrome (ACS) patients are at very high risk for recurrent events and mortality, despite the availability of effective pharmacological approaches. In 2018, the ACS EuroPath Survey, performed in collaboration with 555 Eu...
Asiiat S Alieva,Lale Tokgözoğlu,Kausik K Ray et al.
Asiiat S Alieva et al.
The evidence of the causal role of low-density lipoprotein cholesterol in the development of atherosclerotic cardiovascular disease is well-established. The clearly identified common position of the European guidelines proclaims necessity t...
Implementation of clinical practices and pathways optimizing ACS patients lipid management: Focus on eight European initiatives [0.03%]
欧洲八项优化ACS患者血脂管理临床实践和路径的实施重点
Marco Alings,Olivier Descamps,Benoit Guillon et al.
Marco Alings et al.
Post-acute coronary syndrome (ACS) patients are at very high cardiovascular risk. Despite current guidelines strongly recommend to reduce LDL-C levels and initiation of high-intensity statins as early as possible in patients admitted with a...
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project [0.03%]
急性冠脉综合征患者的调脂治疗和低密度脂蛋白胆固醇目标达标情况：来自ACS患者登记的研究结果
Ulf Landmesser,Angela Pirillo,Michel Farnier et al.
Ulf Landmesser et al.
Background and aims: Post-acute coronary syndrome (ACS) patients are at very high risk for recurrent events and mortality, despite the availability of effective pharmacological approaches. Aim of this survey was to evalua...
Prevalence and relationship between metabolic syndrome and risk of cardiovascular disease: Evidence from two population-based studies [0.03%]
代谢综合征的流行率及其与心血管疾病风险的关系：两项基于人群的研究证据
Asiiat S Alieva,Elena Olmastroni,Olga V Reutova et al.
Asiiat S Alieva et al.
Background and aim: The metabolic syndrome (MetS) has become one of the most important clinical issues in the cardiovascular field for this decade because of the marked increase in cardiovascular (CV) risk associated with...
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia [0.03%]
注册登记中心如何增强遗传性血脂异常的知识和特征研究——意大利LIPIGEN及其他家族高胆固醇血症网络的经验
Marta Gazzotti,Manuela Casula,Elena Olmastroni et al.
Marta Gazzotti et al.
Familial hypercholesterolemia (FH) is a common genetic disorder of lipid metabolism, still underdiagnosed and undertreated in the general population. Pathology registers could play a crucial role in the creation of a comprehensive and integ...
Hypercholesterolemia and cardiovascular disease: Focus on high cardiovascular risk patients [0.03%]
高胆固醇和心血管疾病：重点关注高心血管风险患者
Gerald F Watts,Alberico L Catapano,Luis Masana et al.
Gerald F Watts et al.
The widespread use of statins has largely improved the treatment of hypercholesterolemia, but many patients still fail to achieve the LDL-C targets recommended by guidelines. Furthermore, some patients continue to present a very high cardio...
Hypercholesterolemia and cardiovascular disease: What to do before initiating pharmacological therapy [0.03%]
高胆固醇和心血管病：在开始药物治疗前应该做什么
Bernhard Föger,Catriona Jennings,Angela Pirillo et al.
Bernhard Föger et al.
The availability of efficient lipid-lowering drugs has substantially reduced the incidence and mortality for cardiovascular disease (CVD). Despite that, CVD still represents a major cause of death and disability; efforts are thus required t...
The prevalence of cardiovascular risk factors and cardiovascular disease among primary care patients in Poland: results from the LIPIDOGRAM2015 study [0.03%]
波兰初级保健患者心血管危险因素和心血管病患病率：LIPIDOGRAM2015研究结果
Jacek J Jóźwiak,Krzysztof Studziński,Tomasz Tomasik et al.
Jacek J Jóźwiak et al.
Background and aim: To estimate the prevalence of cardiovascular (CV) disease and CV risk factors among Polish patients. Methods: A nat...